Hormone replacement therapy as treatment of breast cancer - A phase II study of Org OD 14 (tibilone)

British Journal of Cancer

Volumn 73, Issue 9, 1996, Pages 1086-1088

  O'Brien, M E R ^a   Montes, A ^a   Powles, T J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Hormone replacement therapy; Org OD 14; Tibilone

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN; TIBOLONE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER HORMONE THERAPY; CLINICAL TRIAL; DEPRESSION; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIVER FUNCTION TEST; NAUSEA; PAROTITIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VAGINA BLEEDING;

EID: 0030001609     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.209     Document Type: Article

References (13)

1. DUPONT WD AND PAGE DL. (1991). Menopausal oestrogen replacement therapy and breast cancer. Arch. Inter. Med., 151, 67-72.
2. HAYWARD JL, CARBONE PP, HEUSON JC, KUMAOKA S, SEGALOFF A AND RUBENS RD. (1977). Assessment of response to therapy in advanced breast cancer. Br. J. Cancer, 35, 292-298.
3. IVESON TJ, AHERN J AND SMITH IE. (1993). Response to third-line endocrine treatment for advanced breast cancer. Eur. J. Cancer, 29A(4), 572-574.
4. JACKSON IM, LITHERLAND S AND WAKELING AE. (1991). Tamoxifen and other antioestrogens. In Medical Management of Breast Cancer. Powles TJ, Smith IE (eds) pp. 51-60. Martin Dunitz: London
5. LINDSAY R, HART DM, PURDIE D, FERGUSON MM, CLARK AS AND KRASEZEWSKI A. (1978). Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. Clin. Sci. Mol. Med., 54, 193-195.
6. POWLES TJ, HICKISH T, CASEY S AND O'BRIEN M. (1993) Hormone replacement therapy after breast cancer (letter). Lancet, 342, 60-61.
7. SHERWIN BB AND GELFAND MM. (1985). Differential symptom response to parental oestrogen and/or androgen administration in the surgical menopause. Am. J. Obstet. Gynecol., 151, 153-160.
8. SMITH IE, FORD HT, GAZET JC AND POWLES TJ. (1979). Premarin in the management of metastatic breast carcinoma in postmenopausal patients. Clin. Oncol., 5, 159-162.
9. STOLL BA. (1964). Fact and fallacy in the hormonal control of breast cancer. Med. J. Aust., 1, 980-982.
10. TAX L, GOORISSEN EM AND KICOVIC PM. (1987). Clinical profile of Org OD 14. Maturitas, (Suppl 1), 3-13.
11. TAX L. (1991). Hormone replacement therapy? Livial (Org OD 14), a new possibility. In Progress in Basic and Clinical Pharmacology, Schonbaum E. (ed.) pp. 143-159. S. Karger, Basle.
12. TREVOUX R, DIEULANGARD P AND BLUM A. (1983). Efficacy and safety of Org OD 14 in the treatment of climacteric compliants. Maturitas, 5, 89-96.
13. WILSON AJ. (1983). Response in breast cancer to a second hormonal therapy. Rev. Endocrine-related Cancer, 14, 5-11.